Pharmafile Logo
Pharmafocus logo
Advanced Search
handshake-2056023_960_720

NeoVac appoints Jan H Egberts as chief executive officer

September 17, 2025
Analytical & Laboratory Services, Business Services, Clinical Trial Services, Research and Development Devices, Lipid Nanoparticle Technology, Neovac, mRNA Therapies

NeoVac, a clinical-stage biopharma based in Abingdon, UK, has appointed Jan H Egberts as chief executive officer. The company is …

Appointment

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

September 12, 2025
Innovation Award 2025, PlasmidFactory, cell and gene therapy, medical communications, research and development

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with the Innovation Award 2025 of …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Symeres announces acquisition of DGr Pharma

September 11, 2025
Medical Communications, Research and Development DGr Pharma, Symeres, biopharma, contract research

Symeres, a Contract Research, Development and Manufacturing Organization (CRDMO) has acquired DGr Pharma, a drug development-focused consultancy. The acquisition will …

News

Danny Wolin appointed as KJT’s Senior VP of real-world evidence

September 11, 2025
Medical Communications, Research and Development KJT, real-world evidence

Danny Wolin has been appointed as Senior Vice President of Real-World Evidence at KJT. KJT is an evidence-based healthcare consulting …

Appointment

Brian Adams appointed as Kymera’s CLO and Corporate Secretary

September 11, 2025
Kymera, biopharma, corporate, immunology

Brian Adams has been appointed as Kymera Therapeutics’ Chief Legal Officer (CLO) and Corporate Secretary. He will lead Kymera’s legal, …

Appointment

Sapio Sciences and Ultima Genomics form multi-omics research partnership

September 11, 2025
Medical Communications, Research and Development Sapio Sciences, Ultima Genomics, biotech, genomics research

Sapio Sciences and Ultima Genomics have formed a strategic partnership to accelerate genomics research. The collaboration aims to make multi-omics …

News

Richmond Pharmacology promotes Patrick Ramiah to Director

September 8, 2025
Clinical Trial Services, Director of Clinical Project Delivery & Operational Excellence, Richmond Pharmacology, corporate, research and development

Patrick Ramiah has been promoted to Director of Clinical Project Delivery & Operational Excellence at Richmond Pharmacology, effective from 1 …

Appointment
drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

September 8, 2025
Medical Communications, Research and Development AI, BIO4 Campus, Memorandum of Understanding, MultiOmic Health, biotech

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), a biotechnology and life sciences …

News
partnership

Unilab partners with TCS for cloud-led enterprise transformation

September 4, 2025

Tata Consultancy Services (TCS) has announced a partnership with Unilab, a pharma company based in the Philippines, to modernise its …

News

Accro Bioscience and Fosun Pharma sign licence deal for autoimmune therapy in Greater China

September 4, 2025

Accro Bioscience has granted Shanghai-based Fosun Pharma exclusive rights to develop, manufacture and commercialise its experimental therapy AC-201 in Greater …

News

Shaun Chilton appointed as hVIVO Non-Executive Chair

September 3, 2025

hVIVO, a full-service Contract Research Organisation (CRO) involved in human challenge clinical trials has announced that Shaun Chilton has joined …

Appointment

Vitalant and UPMC strengthen partnership in cell and gene therapy

September 3, 2025

Vitalant, a blood and biotherapies provider, is expanding its collaboration with the University of Pittsburgh Medical Center (UPMC), Pennsylvania, US, …

News

Craig Rhodes appointed as Qureight Head of Partnerships

September 2, 2025

Qureight, a techbio company, has appointed Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organisations. The …

Appointment

VITROCELL system aims to improve drug and particle safety testing

September 2, 2025

VITROCELL Systems has launched a new technology called Navetta to support researchers testing the safety of drugs and airborne particles …

News
FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

FDA approves Moderna’s updated COVID-19 vaccines targeting new variant

September 1, 2025
FDA

The US Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccines, Spikevax and mNEXSPIKE, intended to target the …

News
Lilly secures conditional MHRA approval for new blood cancer treatment

Lilly secures conditional MHRA approval for new blood cancer treatment

September 1, 2025

The UK’s Medicines and Healthcare products Regulatory Agency has granted conditional marketing authorisation for Eli Lilly’s pirtobrutinib (Jaypirca). This new …

News

Rare and severe epilepsies – current treatments and advance therapeutics

August 29, 2025
Medical Communications, Research and Development Neurology, UCB, epilepsy, epilepsy treatment, rare epilepsies

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

Rotzinger launches modular filling and capping platform for over-the-counter products

August 29, 2025
Manufacturing Services, Manufacturing and Production Devices, Rotzinger PharmaPack, manufacturing and production

Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle a wide range of over-the-counter …

News

Er-Kim to distribute CNX Therapeutics’ oncology drugs across Europe and Turkey

August 29, 2025
Logistics & Distribution, Manufacturing and Production, Mergers and Acquisitions CNX Therapeutics, Corporate, Er-Kim, Oncology, central nervous system disorders, critical care

Turkish pharma company, Er-Kim, has signed a distribution agreement with CNX Therapeutics to expand access to a portfolio of oncology …

News
hospital

The Pharma Files: With Professor Hatim Abdulhussein from Health Innovation Kent Surrey Sussex

August 28, 2025
Medical Communications, Research and Development Corporate, GP, Health Innovation Kent Surrey Sussex, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026